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Cortactin Is a Substrate of Activated Cdc42-Associated
Kinase 1 (ACK1) during Ligand-induced Epidermal
Growth Factor Receptor Downregulation
Laura C. Kelley¤, Scott A. Weed*
Department of Neurobiology and Anatomy, Program in Cancer Cell Biology, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, West Virginia,
United States of America
Abstract
Background: Epidermal growth factor receptor (EGFR) internalization following ligand binding controls EGFR downstream
pathway signaling activity. Internalized EGFR is poly-ubiquitinated by Cbl to promote lysosome-mediated degradation and
signal downregulation. ACK1 is a non-receptor tyrosine kinase that interacts with ubiquitinated EGFR to facilitate EGFR
degradation. Dynamic reorganization of the cortical actin cytoskeleton controlled by the actin related protein (Arp)2/3
complex is important in regulating EGFR endocytosis and vesicle trafficking. How ACK1-mediated EGFR internalization
cooperates with Arp2/3-based actin dynamics during EGFR downregulation is unclear.
Methodology/Principal Findings: Here we show that ACK1 directly binds and phosphorylates the Arp2/3 regulatory protein
cortactin, potentially providing a direct link to Arp2/3-based actin dynamics during EGFR degradation. Co-
immunoprecipitation analysis indicates that the cortactin SH3 domain is responsible for binding to ACK1. In vitro kinase
assays demonstrate that ACK1 phosphorylates cortactin on key tyrosine residues that create docking sites for adaptor
proteins responsible for enhancing Arp2/3 nucleation. Analysis with phosphorylation-specific antibodies determined that
EGFR-induced cortactin tyrosine phosphorylation is diminished coincident with EGFR degradation, whereas ERK1/2 cortactin
phosphorylation utilized in promoting activation of the Arp2/3 regulator N-WASp is sustained during EGFR downregulation.
Cortactin and ACK1 localize to internalized vesicles containing EGF bound to EGFR visualized by confocal microscopy. RNA
interference and rescue studies indicate that ACK1 and the cortactin SH3 domain are essential for ligand-mediated EGFR
internalization.
Conclusions/Significance: Cortactin is a direct binding partner and novel substrate of ACK1. Tyrosine phosphorylation of
cortactin by ACK1 creates an additional means to amplify Arp2/3 dynamics through N-WASp activation, potentially
contributing to the overall necessary tensile and/or propulsive forces utilized during EGFR endocytic internalization and
trafficking involved in receptor degradation.
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Introduction
Ligand-induced endocytic regulation of EGFR trafficking is
utilized as a key mechanism for modulating growth factor
signaling by controlling levels of EGFR surface expression [1].
Ligand-bound, dimerized EGFR is rapidly internalized by
clathrin-mediated endocytosis (CME), where it traffics to early
endosomes and is segregated to either multivesicular endosomes
(or ‘‘bodies’’; MVBs) for lysosomal-mediated degradation, or
sorted to recycling endosomes and reinserted into the plasma
membrane [2]. Endocytic internalization of activated EGFR is
regulated by multiple interacting factors, including receptor
ubiquitination by Cbl, binding to the adaptor proteins Grb2 and
AP-2, and receptor acetylation [3,4,5]. In addition to CME,
EGFR can be internalized by recruitment into cholesterol-rich
caveolae [6], macropinocytosis [7] or by circular dorsal ruffles
generated from cortical actin polymerization [8]. These CME-
independent mechanisms are typically employed by cells either
exposed to high experimental EGF concentrations or in cells with
increased levels of surface EGFR expression [1,2]. EGFR
overexpression is a frequent occurrence in many cancers that
corresponds to poor clinical outcome, including breast [9] and
head and neck squamous cell carcinoma (HNSCC) [10].
Activation of EGFR is requisite for receptor internalization,
triggering downstream activation of additional non-receptor
tyrosine kinases that participate in the internalization process
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[11,12]. ACK1 is a multidomain non-receptor tyrosine kinase that
contributes to EGFR internalization and subsequent vesicular
trafficking (reviewed in [13]). EGF stimulation recruits ACK1 to
activated EGFR through an ACK1 carboxyl-terminal region
highly homologous to the EGFR binding protein Mig6, which in
turn activates ACK1 kinase activity [14,15]. ACK1 also interacts
with clathrin heavy chain [16,17] and Grb2 [14], providing
additional attachment points to the endocytic machinery. While
ACK1 is well positioned to govern EGFR CME, studies
manipulating ACK1 expression levels to evaluate the impact of
ACK1 on EGFR internalization have yielded opposing results. In
some cases ACK1 overexpression impairs and knockdown
promotes EGFR internalization [18,19]. These findings are in
agreement with studies on transferrin receptor CME with the
ACK1 splice variant ACK2 [20]. Other work indicates that ACK1
knockdown suppresses EGFR internalization and degradation
[15]. This effect was verified by expression of the ACK1 Mig6
domain and with an ACK1 ubiquitin-binding deficient mutant
[21,22]. Like EGFR, in some instances ACK1 itself is downreg-
ulated following EGF stimulation due to Nedd4 ubiquitination,
targeting ACK1 for either conventional proteosomal [21] or
lysosomal [23] degradation depending on the specific Nedd4
isoform. Nedd4-1 ubiquitination of ACK1 is required for EGFR
degradation, indicating that at least a subset of EGFR/ACK1
complexes are targeted for vesicular-mediated co-destruction.
Supporting these biochemical findings, activated ACK1 is
enriched in clathrin-coated pits and colocalizes EGFR in early
endosomal vesicles following EGF stimulation [15,17,18], suggest-
ing that ACK1 activity regulates EGFR vesicle trafficking in the
clathrin pathway.
In addition to collective tyrosine kinase activity at clathrin
coated pits, receptor internalization by CME involves coordinate
regulation of the cortical actin cytoskeleton by actin regulatory
proteins (reviewed in [24]). Activation of Arp2/3 complex, a major
actin nucleation apparatus, results in dynamic branched actin
network formation at the site of clathrin coated pits that
contributes to vesicle invagination, scission and intracytoplasmic
transport [25]. Arp2/3 complex activity is stimulated by proteins
termed nucleation promoting factors (NPFs) [26]. The type I NPFs
of the WASp protein family N-WASp and WASH play important
roles in governing Arp2/3 actin polymerization that drives CME
and vesicle trafficking [27]. In addition to type I NPFs, the type II
NPF cortactin plays a direct role in regulating CME and vesicle
motility [28,29,30]. Cortactin links the Arp2/3 F-actin network to
CME through binding of its carboxyl terminal SH3 domain to the
large GTPase dynamin2 [31,32]. Cortactin and dynamin2 are
both tyrosine phosphorylated by Src, events that are required for
each protein to function during CME [33,34]. In the case of
cortactin, tyrosine phosphorylation by Src or Abl-family kinases
occurs on three tyrosine residues (Y421, 466 and 482 in rodent
forms; Y421, 470 and 486 in human) that create docking sites for
the adaptor Nck1, which in turn complexes with N-WASp and
WIP to amplify Arp2/3 nucleation and enhance actin polymer-
ization levels [35,36]. In addition to promoting actin nucleation
during endocytosis, the cortactin SH3 domain also binds Hip1R to
suppress actin dynamics during CME [37], indicating that
cortactin serves as an important intersection point in regulating
endocytic actin polymerization by phosphorylation -independent
and -dependent processes.
EGFR internalization and lysosomal degradation relies in part
on direct interactions between the activated receptor and F-actin
[38]. Additionally, cortactin modulates EGFR internalization
through actin-based interactions with the adaptor protein CD2AP
in circular dorsal ruffles, which also require cortactin tyrosine
phosphorylation to form [36,39]. While these studies did not
evaluate EGFR degradation, subsequent work in tumor cells with
amplified cortactin gene levels indicates that cortactin upregula-
tion prevents EGFR degradation [40], although the mechanism
for this is unclear. Here we report that cortactin interacts with
ACK1 to potentially regulate EGFR degradation. Cortactin is
directly phosphorylated by ACK1 and both proteins localize in
vesicles with ligand bound EGFR. Downregulation of cortactin
tyrosine phosphorylation is coincident with EGFR degradation,
while knockdown of ACK1 or cortactin attenuates EGFR
dowregulation through the cortactin SH3 domain. Our results
provide evidence for a novel linkage between ACK1 and cortactin
that may play an important role in coupling EGFR to the actin
cytoskeleton to facilitate EGFR degradation.
Materials and Methods
Cell Culture and Transfection
COS1 and 293T cells (purchased from the American Type
Culture Collection) were maintained in DMEM (Mediatech)
containing 10% FBS (HyClone), 1% L-glutamine and 1%
penicillin-streptomycin. 1483 and 584 HNSCC cell lines [41,42]
were maintained as described [43]. COS1 cells (16106) were
transfected with 5 micrograms of plasmid DNA using SuperFect
(Qiagen). 293T, 1483 and 584 cells (36106) were transfected with
2 micrograms of plasmid DNA or siRNA using the Nucleofector I
device (Amaxa Biosystems). Control and human targeted siRNA
for ACK1 (59-AAGGUCAGCAGCACCCACUAU-39) were pur-
chased from Thermo Scientific. Cortactin siRNA (catalog #
SI00300160) was purchased from Qiagen.
Cloning of Murine ACK1
Murine ACK1 (GenBank # AF037260) was cloned using two
sets of degenerate oligonucleotide primers (primer 1: 59-GA(T/
C)ACNTGGATGTT(T/C)GGNGT-39; primer 2: 59-
TGGGA(A/G)ATGTT(T/C)ACNTA(T/C)GG-30; primer 3: 59-
GGNGG(A/G)TCCATNGG(A/G)TTNCC-39 and primer 4:
59;TCNGG(A/G)AANCCCCA(A/G)CA(A/G)TG-39. These
primers were used in nested PCRs to generate a 450 bp probe
from a mouse brain cDNA library (Novagen). This probe was
labeled with 32P-dCTP using the RadPrime DNA labeling system
(Invitrogen) and used to screen a mouse brain lambda GT10
cDNA library (Stratagene). Positive overlapping clones were
identified after three rounds of screening with high stringency
conditions. The reconstructed ACK1 sequence consisted of a
1,002 amino acid open reading frame with a polyadenylation tail,
but lacked a Kozak consensus sequence with an initiation
methionine. The 59 ACK1 sequence was isolated using a two-
step nested PCR approach. The first step used the ACK1 specific
primer 59-ACTGGCATGGGAGAAAGTCCG-39 with a T7
terminator primer homologous to the vector sequence. The
product from this reaction was used as the template for the second
reaction using the ACK1 specific primer 59-TGTTCTTGCAT-
GACATAGTGG-39 with a primer homologous to the SP6 vector
sequence. This reaction generated a 1 kb PCR product containing
.600 bp overlap with the original isolated ACK1 cDNA. A
Kozak sequence and initiation methionine were identified 53
amino acids upstream from the 59-end of the original ACK1 clone.
Additional PCR was conducted to generate the full-length murine
ACK1 coding sequence.
Mammalian Expression Constructs
For generating HA-tagged ACK1 variants, full-length ACK1
cDNA was excised from pBluescript SK+ as a BamHI/EcoRV
ACK1 and Cortactin in EGFR Regulation
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fragment and subcloned into BamHI/EcoRV digested pSV
containing a 59 HA epitope tag. The kinase null K158R (KR)
and Cdc42-binding null H464/H467Q (BD) ACK1 variants were
produced by site directed mutagenesis (QuickChange; Stratagene).
Myc-tagged ACK1 constructs were produced by BamHI/EcoRI
digestion of pSV-HA ACK1 constructs and subcloning the ACK1
fragments into pRK5Myc [44]. Myc-Cdc42, Myc-RhoA, FLAG-
cortactin and CMV-Src527F constructs have been described
previously [44,45,46,47].
Recombinant Protein Production
The ACK1 coding sequence was PCR amplified as an EcoRI/
BglII fragment and subcloned into the baculoviral expression
vector pAcHLT-B (Pharmingen). Baculovirus production and
purification of 6X-His ACK1 was essentially as described [48].
GST-cortactin proteins were produced and purified as before [49].
To produce GST-cortactin Y421/466/482F (triple tyrosine
mutant; TYM), the coding sequence of FLAG-cortactin TYM
[50] was PCR amplified with flanking BamHI/EcoRI ends and
subcloned into pGST-parallel 2 [49].
Kinase Assays
Wild type and TYM GST-cortactin proteins were incubated
with or without 6X-His ACK1 or Src (Upstate) in 50 millimolar
HEPES (pH=7.0), 5 millimolar MgCl2, 5 millimolar MnCl2 and
10 microcuries [gamma32P]ATP (PerkinElmer) in 50 microliters.
Reactions were incubated at 30uC for 10 min and terminated by
the addition of hot 2X-SDS sample loading buffer. Reactions were
resolved by SDS-PAGE, the gels dried and subjected to
autoradiography. Autoradiograms were quantified by ImageJ.
Enzyme kinetics for cortactin phosphorylation by ACK1 were
calculated using the predicted molecular weight for ACK1
including the 6X-His tag (119.33 kilodaltons) and autoradiogram
band intensities to generate a Lineweaver-Burke plot and the
subsequent KM value.
Antibodies
Anti-ACK1 (clone A-11) and EGFR (clone 1005) were
purchased from Santa Cruz. Anti-phosphotyrosine (RC 20) was
purchased from BD Transduction. Anti-Cdc42, RhoA, Anti-
FLAG (DDDDK tag), anti-Myc epitope tag (4A6) and anti-beta-
actin were purchased from EMD Millipore. Anti-cortactin (4F11)
and anti-pS418 cortactin were previously described [51,52]. Anti-
pY421 cortactin was from Invitrogen. Anti-HA (3F10) was from
Roche.
Immunoprecipitation and Western Blotting
For immunoprecipitations, cells were lysed in NP40 buffer (20
millimolar HEPES-KOH, pH 7.8, 50 millimolar KCl, 1 millimo-
lar EDTA and 1% NP40). Five micrograms of primary antibody
(anti-cortactin, EGFR, and HA) were incubated with 0.5
milligrams clarified lysates for 2 h at 4uC, then incubated with
40 microliters of Protein A/G beads (Thermo Scientific) for 1 h at
4uC. FLAG immunoprecipitations were preformed with 40
microliters of anti-FLAG M2 affinity gel (Sigma). Immune
complexes were collected by centrifugation, washed twice with
NP40 Buffer, separated by SDS-PAGE and Western blotted as
described [50]. In some cases, cells were serum starved for 16 h
and stimulated with 100 nanograms/milliliter EGF (Millipore)
Figure 1. ACK1 mediates Cdc42-induced cortactin tyrosine phosphorylation. (A) COS1 cells were cotransfected with FLAG-cortactin WT
and Myc-tagged Cdc42 constructs as indicated. EV; empty vector. Cells were lysed 18 h after transfection, FLAG-cortactin immunoprecipitated and
total cortactin tyrosine phosphorylation analyzed by Western blotting with a pan anti-phosphotyrosine antibody (pTyr). The blot was then stripped
and reprobed for total cortactin levels (Cort). Equal amounts of total cell lysates were blotted in parallel with anti-Cdc42 antibodies to confirm GTPase
expression. Ratios of tyrosine phosphorylated (pTyr) cortactin to total cortactin levels are indicated at the bottom. Blots are representative from $
three independent experiments. (B) ACK1 overexpression induces cortactin tyrosine phosphorylation. COS1 cells transfected with empty HA vector
(EV), HA-ACK1 wild-type (WT), kinase dead (KR) (K-R mutation at amino acid 158 in the kinase domain) and a Cdc42 binding-null mutant (BD) (H-A
mutation of codons 464 and 467 in the CRIB domain) were immunoprecipitated from lysates with anti-FLAG or anti-HA antibodies. FLAG-cortactin
and HA-ACK1 proteins were evaluated for phosphotyrosine levels by Western blotting (pTyr). Expression levels for each protein were evaluated by
stripping and reblotting with anti-cortactin and anti-HA antibodies as indicated. Ratios of tyrosine phosphorylated (pTyr) cortactin to total cortactin
levels are indicated at the bottom. Blots are representative from three independent experiments.
doi:10.1371/journal.pone.0044363.g001
ACK1 and Cortactin in EGFR Regulation
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prior to immunoprecipitation and/or Western blotting. Band
intensities were quantified using ImageJ.
Confocal Microscopy
Cells were serum-starved for 16 h and stimulated with 100
nanograms/milliter unlabeled EGF (Millipore) or Alexa Fluor-488
conjugated EGF (Invitrogen) for 30 minutes before fixation. Cells
were fixed with fresh 4% formaldehyde and permeabilized with
0.4% Triton X-100 in PBS. Primary antibodies listed were diluted
with 5% BSA in PBS. Secondary antibodies used were Alexa Fluor
405 goat anti-rabbit and Alexa Fluor 647 goat anti-mouse
(Molecular Probes). F-actin was labeled with rhodamine-conju-
gated phalloidin (Molecular Probes). Cells were mounted in
Fluoromount-G (Southern Biotech) and imaged with a Zeiss
LSM510 confocal microscope using AIM software (Carl Zeiss
MicroImaging). Invadopodia and matrix-degradation assays were
preformed as previously described [47].
Results
Activation of Cdc42 Enhances Cortactin Tyrosine
Phosphorylation through ACK1
Our previous work demonstrated that cortactin tyrosine
phosphorylation is regulated in part by the small GTPase Rac1
[50]. To determine if other Rho family members influence
cortactin tyrosine phosphorylation, we conducted a series of co-
transfection experiments utilizing dominant negative and consti-
tutive active constructs encoding the Rac1-related GTPases RhoA
and Cdc42 with FLAG-tagged cortactin and assayed total
cortactin tyrosine phosphorylation by Western blotting. Expres-
sion of RhoA activation variants caused no detectible changes in
cortactin tyrosine phosphorylation (Figure S1). However, co-
expression of constitutive active Cdc42 (L61) consistently resulted
in . six-fold increases in cortactin tyrosine phosphorylation
(Figure 1A). Activated Cdc42 is the only small GTPase that
directly interacts with the tyrosine kinase ACK1 through a
conserved Cdc42/Rac interaction binding (CRIB) motif [53],
stimulating ACK1 tyrosine kinase activity [54,55]. To determine if
ACK1 was the kinase potentially responsible for cortactin tyrosine
phosphorylation downstream of activated Cdc42, we conducted
FLAG-cortactin co-transfection experiments with HA-tagged wild-
type (WT) ACK1, kinase null (KR) and Cdc42 binding null (BD)
mutant constructs. Analysis of tyrosine phosphorylation status by
Western blotting indicated a four-fold increase in cortactin
phosphorylation when co-expressed with wild type ACK1. Co-
expression of ACK1 KR did not elevate cortactin tyrosine
phosphorylation levels, whereas ACK1 BD expression resulted
in a 1.8 fold increase (Figure 1B). The level of cortactin tyrosine
phosphorylation corresponded with the degree of autophosphory-
lation present in the assayed ACK1 constructs (Figure 1B), with
the low kinase activity of ACK1 BD likely due to Cdc42-
independent activation [13]. These data collectively suggest that
Figure 2. ACK1 directly phosphorylates cortactin at Y421/466/482. (A) Characterization of purified ACK1. Recombinant 6X-histidine tagged
recombinant ACK1 was purified from SF9 cells and 5 micrograms stained with either Coomassie blue (left) or analyzed by Western blotting with anti-
ACK antibodies (middle). Kinase activity was assayed by analyzing autophosphorylation (Autophos) using 0.5 micrograms of 6X-His ACK1 incubated
with gamma-32P-ATP for 10 min at 30uC. The reaction was evaluated by SDS-PAGE and autoradiography (right). The position of molecular weight
standards is shown on the left and 6X-His ACK1 on the right. (B) Identification of cortactin tyrosine residues phosphorylated by ACK1. Purified GST-
cortactin murine wild type (WT) or Y421/466/482F (triple tyrosine mutant; TYM) (0.5 micrograms) were incubated in kinase assays without or with 3U
of purified Src (left) or with the indicated amounts of purified 6X-His ACK1 (middle and right) in the presence of [gamma-32P]ATP. Reactions were
separated by SDS-PAGE and analyzed by audioradiography. Arrows indicate the positions of phosphorylated GST-cortactin and 6X-His ACK1 (left). (C)
Determination of the KM of ACK1 for cortactin. Graphical representation showing ACK1 phosphorylation kinetics for cortactin calculated from the
kinase assay in B (right panel). Percent of maximum phosphorylation signal measured by densitometry is represented on the ordinate versus
concentration of ACK1 (in micrograms) on the abscissa. The calculated KM for cortactin phosphorylation is shown. Data in B and C are representative
from three independent experiments. (D) ACK1 knockdown reduces cortactin phosphorylation on tyrosine 421. 1483 cells transfected with scrambled
control (Ctl) siRNA or ACK1-targeting siRNA were lysed and analyzed by Western blotting for ACK1 knockdown (ACK1) and cortactin pY421
phosphorylation (Cort pY421). Beta actin was blotted to verify equivalent protein loading. Blots are representative of two independent experiments.
doi:10.1371/journal.pone.0044363.g002
ACK1 and Cortactin in EGFR Regulation
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Cdc42 stimulates cortactin tyrosine phosphorylation through
activation of ACK1.
ACK1 Directly Phosphorylates Cortactin on Tyrosines
421/466/482
Phosphorylation of cortactin on tyrosines 421, 466 and 482 by
several non-receptor tyrosine kinases indicates that these residues
serve as important regulatory targets that mediate signals
responsible for governing cortical actin-based processes. To
determine if ACK1 directly phosphorylates cortactin on these
residues, we generated baculovirus encoding full-length 6X-
histidine tagged recombinant ACK1 and purified the kinase from
infected SF9 cells. Purified ACK1 migrated at a Mr of 145 kDa by
SDS-PAGE, similar to the mobility observed in other cell systems
[14,16] and possessed functional kinase activity as determined by
autoradiographical analysis of autophosphorylation (Figure 2A).
Incubation of 6X-His ACK1 with GST-cortactin wild type (WT)
in kinase reactions containing [gamma-32P]ATP resulted in GST-
cortactin phosphorylation similar to levels observed when
cortactin was incubated with purified Src (Figure 2B). Incubation
of GST-cortactin containing tyrosine to phenylalanine mutations
at Y421, Y466 and Y482 (triple tyrosine mutant; TYM) with 6X-
His ACK1 nearly abolished cortactin phosphorylation (Figure 2B),
with residual phosphorylation of additional sites evident at
extended autoradiogram exposure times (data not shown).
Increasing amounts of 6X-His ACK1 with fixed amounts of
GST-cortactin WT resulted in saturable levels of cortactin
phosphorylation (Figure 2B and C), with a calculated Michaelis
constant for cortactin phosphorylation equaling ,140.7 nM. To
evaluate the level of endogenous phosphorylation of the identified
cortactin tyrosine sites by ACK1 in cells, 1483 HNSCC cells were
transfected with non-targeting (Ctl) or ACK1-targeted small
interfering (si)RNA. Immunoblot analysis indicated an 82%
knockdown of ACK1 expression, which corresponded with an
84% decrease in cortactin phosphorylation at tyrosine 421
(Figure 2D). These results collectively indicate that ACK1 directly
phosphorylates cortactin primarily at Y421/Y466/Y482 in a
manner similar to other cortactin-targeting tyrosine kinases.
The Cortactin SH3 Domain Mediates Binding to ACK1
In order to determine how cortactin interacts with ACK1, 1483
HNSCC cells were transfected with Myc-tagged ACK1 (to
enhance ACK1 detection) and assayed for cortactin binding by
co-immunoprecipitation. Myc-ACK1 precipitated with endoge-
nous cortactin (Figure 3A), suggesting the two proteins interact.
The immunoprecipitation was specific, since beads lacking anti-
cortactin antibody did not precipitate Myc-ACK1 (Figure S2). We
next cotransfected Myc-ACK1 with FLAG-cortactin deletion
Figure 3. Identification of the ACK1 binding region in cortactin. (A) Endogenous cortactin was immunoprecipitated from 1483 cells
transfected with empty Myc vector (EV) or with Myc-tagged ACK1. Non-transfected cells were mock precipitated (Bead Only) as background control.
Immune complexes were assayed by Western blotting with anti-Myc and anti-cortactin and antibodies. Total cell lysates from transfected cells were
probed with anti-Myc, Anti-ACK1 and anti-cortactin antibodies. (B) Clarified lysates from 293T cells coexpressing Myc-tagged ACK1 with either empty
FLAG vector (EV), full-length (FL), N-terminal (NT), C-terminal (CT) or SH3-binding deficient (W525K) FLAG-cortactin constructs (schematic diagram at
top right) were immunoprecipitated with anti-FLAG antibodies. Membranes were immunoblotted with anti-ACK1, anti-Myc, anti-FLAG and anti-
cortactin antibodies (left). Expression of recombinant ACK1 and cortactin proteins for each transfection condition were confirmed by Western blotting
of total cells lystes with the indicated antibodies (bottom right). The positions of molecular weight markers are shown on the right. All blots are
representative of $ three independent experiments.
doi:10.1371/journal.pone.0044363.g003
ACK1 and Cortactin in EGFR Regulation
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constructs in order to map the cortactin subdomian(s) responsible
for ACK1 binding. Myc-ACK1 precipitated with FLAG-cortactin
full length (FL) and carboxyl terminal (CT) (amino acids 350–546)
proteins, but not with a FLAG-cortactin protein containing the
amino terminal (NT) Arp2/3 and F-actin binding regions
(Figure 3B). These results localize the cortactin binding site for
ACK1 to the carboxyl-terminal half of cortactin. The cortactin
SH3 domain at the carboxyl-terminus binds to proline-rich
segments in several proteins involved in actin regulation and
endocytosis [56] while ACK1 contains a several putative proline-
rich segments within its carboxyl terminus [53]. To determine if
the cortactin SH3 domain binds to ACK1, Myc-ACK1 was co-
transfected with a cortactin construct containing a point mutation
within the SH3 domain that ablates binding to proline-rich ligands
(W525K) [46]. This protein displays retarded electrophoretic
mobility in SDS-PAGE, presumably due to altered conformation
Figure 4. Cortactin localizes with ACK1 in vesicles containing ligand-bound EGFR. (A) 1483 cells serum starved for 16 h were stimulated
with 100 nanograms/milliter Alexa Fluor-488 conjugated EGF (green) for 30 min. Cells were fixed and labeled with phalloidin (Actin; pseudocolored
white) and anti-EGFR antibodies (pseudocolored red). Cells were evaluated by confocal microscopy and images rotated 45u and 90u as indicated to
demonstrate EGF/EGFR colocalization throughout the z-plane. (B) Serum starved (No Tx) 1483 cells were stimulated with FITC-EGF (pseudocolored
white) as in (A). Cells were fixed and labeled with anti-ACK1 (green) and cortactin (red) antibodies. Confocal images of labeled EGR in the apical (top)
and ventral (bottom) cellular regions are shown. Dashed boxes in the merged images indicate the areas enlarged in the photos to the right. Scale
bars, 20 micrometers.
doi:10.1371/journal.pone.0044363.g004
ACK1 and Cortactin in EGFR Regulation
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introduced by the point mutation as previously observed [46].
FLAG-cortactin W525K failed to co-precipitate Myc-ACK1
(Figure 3B), indicating that cortactin SH3 domain is responsible
for linking cortactin to one or more proline rich sequences in
ACK1.
ACK1 and Cortactin Localize in Vesicles Containing
Ligand-bound EGFR
Since ACK1 and cortactin have been individually shown to
participate in regulating EGFR surface expression following ligand
stimulation [15,18,40], we determined if both proteins localized at
sites containing activated EGFR. Initial experiments in 1483 cells
stimulated with Alexa Fluor-488 conjugated EGF for 30 min
indicated that EGF/EGFR complexes were present throughout
the vertical dimension of the cell when analyzed by whole cell
confocal analysis, demonstrating internalization of activated
EGFR in this system (Figure 4A). Confocal imaging of the apical
and basal planes of fluorescently-labeled EGF stimulated 1483
cells co-immunostained with antibodies against ACK1 and
cortactin indicated co-localization of ACK1 and cortactin at
apical internalization regions as well as in EGF-containing vesicles
at the ventral surface of the cell (Figure 4B). These vesicles
contained activated EGFR that co-localized with cortactin (Figure
S3), collectively demonstrating that cortactin localizes with ACK1-
containing vesicles associated with activated EGFR during
receptor internalization.
In addition to regulating CME, cortactin tyrosine phosphory-
lation has a prominent role in governing podosome and
invadopodia function in invasive cells [47,57,58]. Myc-ACK1
did not localize podosomes or invadopodia in invasive Src-
transformed HNSCC cells, nor did knockdown of ACK1
expression impact the ability of podosomes/invadopodia to
degrade ECM (Figure S4). These results suggest that ACK1 does
not participate in cortactin phosphotyrosine-based signaling
involved in regulating podosome or invadopodia function.
Cortactin Phosphorylation is Differentially Regulated
during EGFR Degradation
The ability of ACK1 to bind and phosphorylate cortactin, along
with the localization of ACK1 and cortactin with EGFR during
ligand stimulated receptor internalization, suggests that cortactin
tyrosine phosphorylation may be modulated during the internal-
ization process. Additionally, EGFR activation stimulates ERK1/
2 activity, which in turn phosphorylates cortactin at S405 and
S418 to regulate cortactin SH3 domain binding to N-WASp and
other proteins [59,60]. To monitor cortactin tyrosine and serine
phosphorylation status during EGFR internalization, Western
blotting of whole cell lysates was conducted with phosphorylation-
specific antibodies against tyrosine 421 (pY421) and serine 418
(pS418). EGF treatment of starved 1483 cells induced cortactin
tyrosine phosphorylation evident at 15 min, which gradually
decreased until it was not detectable two h post stimulation
(Figure 5A). The reduction of cortactin tyrosine phosphorylation
mirrored ligand-induced EGFR downregulation and was not due
to decreased cortactin protein levels. EGF-induced ERK1/2
cortactin phosphorylation persisted throughout the entire time
course and did not decrease during EGFR degradation (Figure 5B).
These results indicate that cortactin tyrosine and serine phos-
phorylation undergoes disparate regulation during EGFR down-
regulation.
The Cortactin SH3 Domain is Required for Ligand-
induced EGFR Downregulation
To determine if a potential ACK1/cortactin linkage contributes
to EGFR internalization, we conducted siRNA knockdown and
rescue experiments of ACK1 and cortactin to evaluate effects on
EGFR degradation. 1483 cells treated with scrambled (Ctl Si)
siRNA demonstrated complete EGFR degradation at two h when
evaluated by immunoprecipation (Figure 6A). RNAi depletion of
ACK1 (ACK1 Si) prevented EGFR downregulation in ligand
stimulated cells, indicating that ACK1 plays an essential role in
promoting EGFR internalization in 1483 cells. Rescue of ACK1
Si cells by expression of Myc-ACK1 restored the ability of 1483
cells to degrade EGFR, albeit with delayed degradation kinetics
(Figure 6A).
Finally, to determine if cortactin plays a similar role to ACK1 in
EGFR downregulation, EGFR degradation was assayed in
cortactin knockdown and rescued 1483 cells following EGF
treatment. Transfection of cortactin siRNA (CTTN Si) resulted in
increased EGFR accumulation in starved cells and slowed EGFR
degradation compared with control siRNA treatment (Figure 6B).
Tranfection of FLAG-cortactin in CTTN Si cells also delayed
EGFR degradation compared to control siRNA cells (Figure 6A).
This result may be due to the inhibitory effects of cortactin
overexpression as previously reported in HNSCC cells [40].
However, rescue of CTTN Si cells with FLAG-cortactin W525K
blocked EGFR degradation in a manner similar to that in
Figure 5. Cortactin tyrosine phosphorylation is downregulated during EGFR degradation. 1483 cells were serum starved for 16 h then
stimulated with 100 nanograms/milliter EGF for the indicated times. Cell lysates were analyzed after stimulation by immunoblotting with anti-EGFR,
anti-cortactin, anti-actin, and anti-cortactin pY241 (A) or anti-cortactin pS418 antibodies (B). Blots are representative of three independent
experiments.
doi:10.1371/journal.pone.0044363.g005
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stimulated cells with ACK1 knockdown (Figure 6A and B).
Overall, this indicates that ACK1 and the cortactin SH3 domain
are required for ligand induced EGFR downregulation, potentially
through a direct interaction between the two molecules.
Discussion
ACK1 has been implicated in multiple aspects of normal
cellular and neoplastic processes, including growth, invasion and
endocytic regulation of growth factor receptors [13]. Ligand
induced downregulation of EGFR is an important regulatory
mechanism for controlling EGFR signaling that involves CME of
the receptor and ultimate trafficking to lysosomes [2,61]. Evidence
to date indicates that regulated actin polymerization at all points of
the internalization pathway is vital in driving the membrane
dynamics necessary for EGFR internalization, with cortactin
serving as an important scaffold by coupling Arp2/3 activity to
cytoplasmic membrane surfaces during internalization [28,34,62].
Our present findings provide evidence that ACK1 directly
phosphorylates cortactin at tyrosine sites that provide enhanced
Arp2/3-based actin polymerization, which may be utilized to
facilitate EGFR internalization. ACK1 associates with the
cortactin SH3 domain, providing a potentially important interac-
Figure 6. EGFR downregulation requires ACK1 and the cortactin SH3 domain. (A) 1483 cells were transfected with non-targeting (Ctl) or
human-specific ACK1 siRNA (ACK1 Si) for 48 h. Murine Myc-ACK1 was subsequently transfected into ACK depleted cells to rescue ACK1 expression.
Cells were serum starved for 16 h and then treated with EGF for the indicated times. Following stimulation, clarified lysates were immunoprecipitated
and immunoblotted with anti-EGFR antibodies. Total cell lysates were immunoblotted with anti-ACK1 and anti-actin antibodies. (B) 1483 cells were
transfected with a non-targeting (Ctl) or cortactin specific siRNA (CTTN Si) for 48 h. Cortactin expression was rescued by transfection with FLAG-
cortactin wild type (WT) or with an SH3-null binding mutant (W525K). Cells were serum starved for 16 h prior to EGF stimulation for the indicated
times. EGFR was immunoprecipated and immunoblotted with anti-EGFR antibodies. Total cell lysates were immunoblotted with anti-cortactin to
verify knockdown and expression of the FLAG-cortactin rescue constructs. Western blotting with anti-actin antibodies was conducted to verify equal
protein loading. Blots are representative of two independent experiments.
doi:10.1371/journal.pone.0044363.g006
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tion point in promoting receptor internalization to regulate EGFR
surface expression.
Our data indicating that Cdc42 stimulates direct ACK1
phosphorylation of cortactin is in agreement with the localization
of these proteins at clathrin coated pits during early endocytic
stages, supporting cortactin as an ACK1 substrate during receptor
internalization [17,29,63]. We show that ACK1 phosphorylates
the canonical cortactin tyrosine residues 421/466/482 that are
also targeted by Src [64], Abl/Arg [36], Fer [65], c-Met [66], Fyn
[67] and HER2 [68]. Src activation triggered by EGFR
contributes to receptor endocytosis and is responsible for
simulating ACK1 activity [69,70]. Src phosphorylation of
cortactin is required for transferrin receptor CME [33,34],
indicating that cortactin is also targeted by Src during endocytosis.
In addition, Abl is activated during EGFR stimulation but plays a
negative role in receptor downregulation [12]. The resultant
aggregate activity of multiple kinases towards the same cortactin
phosphorylation sites during EGFR endocytosis increases the level
of complexity regarding regulation of endocytic events controlled
by cortactin tyrosine phosphorylation. Nevertheless, our direct
phosphorylation data with purified proteins combined with
localization of ACK1 and cortactin with activated EGFR suggests
that at least a subset of cortactin is likely phosphorylated by ACK1
during receptor internalization. The additional low level ACK1
phosphorylation present in cortactin lacking tyrosines 421/466/
482 may be due to targeting of other tyrosine residues
phosphorylated downstream of EGFR [71] or possible phosphor-
ylation of serine/threonine sites due dual specificity of ACK1 [72].
Identification of these additional cortactin phosphorylation sites
targeted by ACK1 remains to be determined.
Deletion mapping and point mutational studies indicate that the
cortactin SH3 domain mediates binding to ACK1. Analysis of the
ACK1 primary sequence by the STRING database (http://string.
ebml.de) indicates that the ACK1 proline rich region contains a
region between amino acids 735–743 (KPQVPPRVP) that is a
partial consensus with proline rich regions in other proteins that
bind the cortactin SH3 domain [73]. We are currently working on
identifying the precise cortactin binding site in ACK1 within the
proline rich region. In addition to ACK1, the cortactin SH3
domain binds to proline rich sequences in CD2AP [39] and
dynamin2 [29] during CME. The multiplex binding of the
cortactin SH3 domain to proteins with different functions likely
delineates specific roles during endocytic receptor internalization.
Cortactin SH3 domain binding to CD2AP links Arp2/3 actin
nucleation to EGFR during internalization through a CD2AP
complex containing Cbl and endophilin [39]. Endophilin contains
an N-BAR (Bin–amphiphysin–Rvs) domain that inserts into the
cytoplasmic plasma membrane face, inducing membrane curva-
ture to initiate vesicle formation [74]. The interaction of cortactin
with dynamin2 has been shown to regulate fission of clathrin
coated vesicles through Src phosphorylation of cortactin and
concurrent regulation of actin dynamics [28,32,34]. Cortactin
binding to ACK1 likely occurs later in the internalization pathway,
since ACK1 localizes at the base of exaggerated elongated tubular
invaginations reminiscent of endosomes present in dynamin-null
cells [17] as well as on early endosomes in other cell types [15].
The sequential binding of cortactin SH3 domain proteins is
supported by a comprehensive analysis of CME using live cell
imaging, where peak recruitment of dynamin2 occurred before
ACK1 to the preassociated cortactin-containing F-actin network
[75]. However, dynamin2 has recently been shown to also regulate
late stages of endosomal budding [76], suggesting overlapping and
redundant functions of cortactin SH3 domain binding proteins in
receptor internalization and trafficking.
The findings that ACK1 and the cortactin SH3 domain are
required for EGFR degradation point to a functional role for this
complex in regulating EGFR surface expression. The loss of
cortactin tyrosine phosphorylation during receptor downregula-
tion (Figure 5A) suggests that ACK1-targeted cortactin tyrosine
residues are dephosphorylated while ACK1 is still bound to
cortactin. EGFR-containing late endosomes are targeted to
MVBs, where dephosphorylation of tyrosine residues in the
EGFR cytoplasmic domain by the ER-associated protein tyrosine
phosphatase PTP1B triggers subsequent lysosomal targeting and
degradation [77]. Fusion of late endosomes containing phosphor-
ylated cortactin and ACK with MVBs would place cortactin in
close proximity to PTP1B, which dephosphorylates cortactin [71].
Dephosphorylated cortactin would be released from the vesicle
surface and recycled with ACK1, or ACK1 may remain
constitutively bound to and degraded with EGFR [21,23]. While
dephosphorylation of cortactin would remove Nck1 docking sites
required for the assembly of N-WASp/WIP Arp2/3 nucleation
complexes, cortactin remains phosphorylated on the ERK1/2
phosphorylation sites important for maintaining the SH3 domain
in an ‘‘open’’ conformation [52,60]. This would to allow binding
to N-WASp and presumably other SH3 domain binding proteins,
providing for and maintaining Arp2/3-based actin polymerization
during vesicle trafficking [78].
In summary, we have demonstrated that cortactin is an ACK1
substrate that potentially links the ACK1 EGFR internalization
pathway to Arp2/3-based cortical actin regulation. It is likely that
this pathway plays important roles in tumor progression, since
elevated expression of ACK1 and cortactin due to gene
amplification is found in several tumor types [79,80], and
dysregulation of ACK1 and cortactin expression alters EGFR
internalization dynamics [18,40]. How cortactin tyrosine phos-
phorylation is regulated by ACK1 and other cortactin kinases
during internalization, as well as an improved understanding how
the binding of cortactin SH3 domain-associated proteins are
orchestrated are important questions for future consideration.
Supporting Information
Figure S1 RhoA activation does not impact cortactin
tyrosine phosphorylation. COS1 cells were cotransfected with
FLAG-cortactin WT and Myc-tagged RhoA constructs as indicat-
ed. EV; empty vector. Cells were lysed 18 h after transfection,
FLAG-cortactin immunoprecipitated and total cortactin tyrosine
phosphorylation analyzed by Western blotting with a pan anti-
phosphotyrosine antibody (pTyr). The blot was then stripped and
reprobed for total cortactin levels (Cort). Equal amounts of total cell
lysates were blotted in parallel with an anti-RhoA monoclonal
antibody to confirm expression of recombinant RhoA forms
(present at a higher Mr than endogenous RhoA in the respective
transfected lanes). Ratios of tyrosine phosphorylated (pTyr)
cortactin to total cortactin levels are indicated at the bottom. Blots
are representative from three independent experiments.
(TIF)
Figure S2 Specificity of the Myc-ACK1-cortactin co-
immunoprecipitation. 293T cells transiently transfected with
Myc-ACK1 were lysed and immunoprecipated with Protein A/G
beads alone (Beads Only) or with Protein A/G beads bound to
anti-cortactin antibody (Anti-CTTN). Immune complexes were
resolved by SDS-PAGE and blotted for ACK1 and cortactin
(Cort) as indicated. A non-specific binding product (NS) is shown
as a control for equal loading. Blots are representative of two
independent experiments.
(TIF)
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Figure S3 Cortactin localizes with vesicles containing
activated EGFR. 1483 cells were serum starved for 16 h and
then left either untreated (No Tx) or stimulated with AlexaFlour-
488 EGF (100 nanograms/milliliter, green) for 30 min before
fixation. Cells were stained with anti-EGFR (red) and anti-
cortactin (blue) antibodies. Confocal images of labeled EGR in the
apical (top) and ventral (bottom) cellular regions are shown. Scale
bars, 20 micrometers.
(TIF)
Figure S4 ACK1 is not a component of cortactin-
containing invasive subcellular structures. (A) 584 cells
cotransfected with activated Src kinase (527F) and Myc-ACK1
were plated on coverslips, fixed and labeled with with rhodamine
phalloidin (Actin), anti-Myc (blue) and anti-cortactin (green)
antibodies. Src-induced podosome rosettes (left panels) are
identified as yellow circular aggregates; individual invadopodia
(right panels) as subnuclear ventral puncta in the merged actin/
cortactin images (white arrows). Arrowheads denote actin/
cortactin containing lamellipodia. (B) 1483 or 584 cells were
transfected with non-targeting siRNA (Ctl) or siRNA targeting
ACK (Si) and analyzed by Western blotting with anti-ACK1 and
anti-actin antibodies. (C) 584 cells expressing activated Src were
plated on FITC-gelatin coated coverslips (pseudocolored white) for
24 h, fixed and labeled with rhodamine phalloidin (Actin; red) and
anti-cortactin (green) antibodies. Scale bar, 20 micrometers.
(TIF)
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